Comparison Between Fimasartan Versus Other Angiotensin Receptor Blockers in Patients With Heart Failure After Acute Myocardial Infarction

• DOI: 10.3346/jkms.2023.38.e202
• Publication Date: 2023-05-30T07:41:48Z
• Authors: Jihoon Kim; Danbee Kang; Sung Eun Kim; Hyejeong Park; Taek Kyu Park; Joo Myung Lee; Jeong Hoon Yang; Young Bin Song; Jin-Ho Choi; Seung-Hyuk Choi; Hyeon-Cheol Gwon; Eliseo Guallar; Juhee Cho; Joo-Yong Hahn
• Keywords: Interquartile range; Stroke

Fimasartan is the most recently developed, potent, and long-acting angiotensin II receptor blocker (ARB). However, data are limited regarding treatment effects of fimasartan in patients with heart failure.